8:30-9:00 | Introduction/Convocation |
Session I: | Overview of Vitamin D (25 minute talks with 5 minute Q & A) |
9:00-9:30 | Historical Overview of Vitamin D from a Public Health Perspective Speaker: Mike Holick, Boston University |
9:30-10:00 | Vitamin D Biology: Overview General Physiology, and Function of Vitamin D Speaker: Hector Deluca, University of Wisconsin-Madison |
10:00-10:30 | Vitamin D: A Global Perspective Speaker: Gerald Combs, USDA/ARS/HNRCGF |
10:30-11:00 | BREAK |
Session 2: | Epidemiology, Demographics and Methodologies (20 Minute Talks-10 Minute Q & A) Session Chair: Anne Looker, NCHS/CDC |
11:00-11:30 | Current Data on Prevalence in the United States: Age and Racial Risk Groups Speaker: Kelley Scanlon, CDC |
11:30-12:00 | Vitamin D Assessment: A Global Perspective of Needs and Current Concerns Speaker: Christel Lamberg-Allardt, University of Helsinki, Finland |
12:00-12:30 | Biomarkers: Functional Indices of Vitamin D Status and Functional Ramifications of Marginal or Deficient Status Speaker: Robert Heaney, Creighton University |
12:30-1:00 | Vitamin D Fortification: Data Needs and Current Status Speaker: Mona Calvo, FDA |
1:00-2:00 | LUNCH |
2:00-2:30 | Panel Discussion 1: Questions |
1. What are five research priorities? 2. What are the major needs with regard to methodologies? |
Session 3: | Current Understanding of the Role of Vitamin D in Health and Potential Mechanisms for Vitamin D-Related Disease (20 Minute Talks-10 Minute Q & A) Session Chair: Gerald Combs, USDA/ARS/HNRCGF |
2:30-3:00 | Overview of Potential Association between Vitamin D, UV Exposure, and Disease Speaker: William B. Grant, Newport News, VA |
3:00-3:30 | Vitamin D and the Immune System Speaker: Margherita Cantorna, Penn State University |
3:30-4:00 | Vitamin D and Cancer: Case Study of Vitamin D and Breast Cancer Speaker: JoEllen Welsh, Notre Dame University |
4:00-4:30 | Nutritional Rickets: Vitamin D, Calcium, or Both? Speaker: John Pettifor, University of Witwatersand, South Africa |
4:30-4:45 | BREAK |
4:45-5:15 | New Methodologies for Probing the Role(s) of Vitamin D in Health Speaker: Jim Fleet, Purdue University |
5:15-5:45 | Panel Discussion 2: Questions |
1. What are the five priority areas in the vitamin D/disease relationship? 2. What are the current obstacles (e.g., methodologies) for the exploration of the vitamin D/health relationship? 3. What is the best approach to addressing vitamin D and health in the international setting? |
6:00-9:00 | Conference Reception: Bethesda Marriott Hotel, 5151 Pooks Hill Road |
Friday, October 10, 2003 |
Session 4: | Developmental, Ethnic/Racial Considerations in Generating Recommendations for Vitamin D (20-Minute Talks-10 Minute Q & A) Session Chair: TBA |
9:00-9:30 | Overview of Current Vitamin D Recommendations Speaker: Connie Weaver, Purdue University |
9:30-10:00 | Pregnancy Speaker: Bonnie Specker, South Dakota State University |
10:00-10:30 | Prenatal/Fetal and Infant Predictors of Bone Health Speaker: Nicolas Bishop, University of Sheffield |
10:30-11:00 | BREAK |
11:00-11:30 | Lactation Speaker: Bruce Hollis, Medical University of South Carolina |
11:30-12:00 | Issues in Establishing Recommendations for Infants and Children Speaker: Frank Greer, Meriter Hospital, Madison, WI |
12:00-12:30 | Adults/Elderly Speaker: Bess Dawson-Hughes, Tufts University |
12:30-1:30 | LUNCH |
1:30-2:30 | Panel Discussion 3: Questions |
1. Are the current dietary recommendations for vitamin D adequate? 2. What are the research priorities: data needs to set meaningful recommendations for different developmental and/or racial/ethnic groups? 3. Given the current state of knowledge what are the public health approaches to achieve vitamin D adequacy? 4. What factors need to be considered with regard to amount, duration, and target groups for dietary or other (UV exposure) interventions/recommendations? 5. How can we account for potential confluence of health messages to create adverse outcomes (UV protection vs. vitamin D adequacy)? 6. Is there a need for special considerations for health disparities? |
Session 5: | Conclusions/Recommendations: Summary Discussion Panel: session chairs, organizers, representatives from sponsoring agencies |
2:30- 3:00 | Questions: |
1. What are key research/program priorities? 2. What are the key program priorities for your agency/program? 3. How best to coordinate agency/organization response to current data needs/public health issues? |
ADJOURN |